AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs
Like with many other pharma giants, AbbVie’s manufacturing expansion will see the company put down roots in North Carolina.
Samsung Biologics posts massive revenue growth as labor union rally sets strike in motion
As Samsung Biologics presented a massive quarterly revenue growth, 2,200 people rallied ahead of a planned labor union strike.
Biovac nets $108M finance package to build Africa’s first fully integrated vaccine plant
Biovac has secured a $108.3 million financing package that will allow the South African pharma company to build the continent’s first end-to-end, multi-vaccine production plant.
Viatris, Teva kick off separate recalls over dissolution, raw material issues
Viatris and Teva Pharmaceutical Industries recently launched separate recalls related to dissolution problems for a common anxiety medication and concerns around an unapproved raw material in a high blood pressure patch, respectively.
Astellas manufacturing chief views reliable supply, bridging research as his production ‘north star’
For Astellas’ chief manufacturing officer, Rao Mantri, Ph.D., production is not just about a reliable supply of a pharmaceutical product. Manufacturing serves as a crucial bridge that helps link promising research to
Starting material sourcing bottlenecks increase US drug shortage risks: report
As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for local drug production with a warning that homes in on the pharmaceutical
Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant
Japan’s Shionogi is joining the spate of drugmakers to unveil a U.S. manufacturing commitment, albeit under slightly different circumstances than its peers.
German CDMO Adragos buys French sterile injectables plant from Sanofi
Adragos Pharma, a German CDMO, snapped up one of Europe’s largest sterile injectables production plants for an undisclosed price from Sanofi.
The Human Side of AI Medical Devices: Why Safety Depends on Design, Not Just Algorithms
As artificial intelligence becomes increasingly embedded in medical devices, most discussions focus on algorithm performance metrics such as accuracy and robustness. However, many real-world safety risks arise not from the model itself
Ardena’s US plant buy pays off as CDMO endures rough geopolitical waters
“You want to be holistic, but within a particular specialty,” Ardena CEO Jeremie Trochu recently told Fierce about how the CDMO is navigating rough geopolitical waters.